Changes in taste resulting from conventional chemotherapy

Authors

DOI:

https://doi.org/10.33448/rsd-v10i14.22467

Keywords:

Antineoplastics; Distorted taste; Dysgeusia; Stomatitis; Oral cavity.

Abstract

Cancer is linked to the disordered increase of cells, has the ability to invade neighboring tissues in the place of origin and/or install itself in distant organs via the bloodstream. Antineoplastic treatment can generate side effects in the oral mucosa, being evident through the appearance of oral mucositis. We can also observe changes in taste, such as: hypogeusia, dysgeusia, ageusia and hypergeusia. The present work aims to review the literature on taste alterations caused by 5-fluorouracil (5-FU), leucovorine, oxaliplatin, gemcitabine, capecitabine, cisplatin, cyclophosphamide, doxorubicin, irinotecan and methotrexate, being conventional antineoplastic drugs. This study was carried out by collecting data from 2009 to 2021, from scientific literature in the PubMed, Lilacs, Cochrane and Scielo databases in English and Spanish, using the key words Antineoplastics; Distorted taste; Dysgeusia; Stomatitis; Oral cavity; together with the Boolean operators “and” and “or”, in order to combine the aforementioned descriptors. Given the above, conventional chemotherapy drugs affect taste cells and biochemical processes related to their cell renewal, generating changes in taste such as hypogeusia, dysgeusia, ageusia and hypergeusia.

References

Acharya, S., Pai, K. M., Bhat, S., Mamatha, B., Bejadi, V. M., & Acharya, S. (2017). Oral changes in patients undergoing chemotherapy for breast cancer. Indian Journal of Dental Research, 28(3), 261–268. https://doi.org/10.4103/ijdr.IJDR_379_16

Aldossary, S. A. (2019). Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomedical and Pharmacology Journal, 12(1), 7–15. https://doi.org/10.13005/bpj/1608

Amézaga, J., Alfaro, B., Ríos, Y., Larraioz, A., Ugartemendia, G., Urruticoechea, A., & Tueros, I. (2018). Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Supportive Care in Cancer, 26(12), 4077–4086. https://doi.org/10.1007/s00520-018-4277-z

Amrutkar, M., & Gladhaug, I. P. (2017). Pancreatic cancer chemoresistance to gemcitabine. Cancers, 9(11), 1–23. https://doi.org/10.3390/cancers9110157

Aprile, G., Mazzer, M., Moroso, S., & Puglisi, F. (2009). Pharmacology and therapeutic efficacy of capecitabine: Focus on breast and colorectal cancer. Anti-Cancer Drugs, 20(4), 217–229. https://doi.org/10.1097/CAD.0b013e3283293fd4

Avau, B., & Depoortere, I. (2016). The bitter truth about bitter taste receptors: Beyond sensing bitter in the oral cavity. Acta Physiologica, 216(4), 407–420. https://doi.org/10.1111/apha.12621

Badowski, M. E. (2017). A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer Chemotherapy and Pharmacology, 80(3), 441–449. https://doi.org/10.1007/s00280-017-3387-5

Bologna-Molina, R., Mosqueda-Taylor, A., Molina-Frechero, N., Mori-Estevez, A. D., & Sánchez-Acuña, G. (2013). Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Medicina Oral, Patologia Oral y Cirugia Bucal, 18(2). https://doi.org/10.4317/medoral.18573

Boltong, A., Keast, R., & Aranda, S. (2012). Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Supportive Care in Cancer, 20(11), 2765–2774. https://doi.org/10.1007/s00520-012-1398-7

de Vries, Y. C., van den Berg, M. M. G. A., de Vries, J. H. M., Boesveldt, S., de Kruif, J. T. C. M., Buist, N., Haringhuizen, A., Los, M., Sommeijer, D. W., Timmer-Bonte, J. H. N., van Laarhoven, H. W. M., Visser, M., Kampman, E., & Winkels, R. M. (2017). Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer. Supportive Care in Cancer, 25(8), 2581–2591. https://doi.org/10.1007/s00520-017-3668-x

de Vries, Y. C., Winkels, R. M., van den Berg, M. M. G. A., de Graaf, C., Kelfkens, C. S., de Kruif, J. T. C. M., Göker, E., Grosfeld, S., Sommeijer, D. W., van Laarhoven, H. W. M., Kampman, E., & Boesveldt, S. (2018). Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls. Food Quality and Preference, 63, 135–143. https://doi.org/10.1016/j.foodqual.2017.09.003

Del Fabbro, E., Orr, T. A., & Stella, S. M. (2017). Practical approaches to managing cancer patients with weight loss. Current Opinion in Supportive and Palliative Care, 11(4), 272–277. https://doi.org/10.1097/SPC.0000000000000300

Demark-Wahnefried, W Peterson, B. L., Winer, E. P., Marks, L., Aziz, N., Marcom, P. K., Blackwell, K., & Rimer, B. K. (2001). Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 19(9), 2381–2389.

Dodde, W. I. W., Maring, J. G., Hendriks, G., Wachters, F. M., Groen, H. J. M., De Vries, E. G. E., & Uges, D. R. A. (2003). Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC. Therapeutic Drug Monitoring, 25(4), 433–440. https://doi.org/10.1097/00007691-200308000-00003

Dooley, M., & Goa, K. L. (1999). Capecitabine. 58(1), 69–76.

Feng, P., Huang, L., & Wang, H. (2014). Taste bud homeostasis in health, disease, and aging. Chemical Senses, 39(1), 3–16. https://doi.org/10.1093/chemse/bjt059

Field, E. A., Longman, L. P., Bucknall, R., Kaye, S. B., Higham, S. M., & Edgar, W. M. (1997). The establishment of a xerostomia clinic: A prospective study. British Journal of Oral and Maxillofacial Surgery, 35(2), 96–103. https://doi.org/10.1016/S0266-4356(97)90683-5

Fox, P. C., Busch, K. A., & Baum, B. J. (1987). Subjective reports of xerostomia and objective measures of salivary gland performance. Journal of the American Dental Association (1939), 115(4), 581–584. https://doi.org/10.1016/S0002-8177(87)54012-0

Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., Vredenburgh, J., Huang, J., Zheng, M., & Cloughesy, T. (2009). Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. Journal of Clinical Oncology, 27(28), 4733–4740. https://doi.org/10.1200/JCO.2008.19.8721

Fujii, H., Hirose, C., Ishihara, M., Iihara, H., Imai, H., Tanaka, Y., Matsuhashi, N., Takahashi, T., Yamaguchi, K., Yoshida, K., & Suzuki, A. (2018). Improvement of dysgeusia by polaprezinc, a Zinc-L-Carnosine, in outpatients receiving cancer chemotherapy. Anticancer Research, 38(11), 6367–6373. https://doi.org/10.21873/anticanres.12995

Fukasawa, T., Orii, T., Tanaka, M., Yano, S., Suzuki, N., & Kanzaki, Y. (2005). Statistical approach to the drug-induced taste disorders based on zinc chelating ability. Yakugaku Zasshi, 125(4), 377–387. https://doi.org/10.1248/yakushi.125.377

Gillis, A., & Eminger, L. (2020). Hypogeusia and hyposmia with topical 5-fluorouracil treatment. JAAD Case Reports, 6(7), 650–651. https://doi.org/10.1016/j.jdcr.2020.04.023

Hejna, M., Köstler, W. J., Raderer, M., Steger, G. G., Brodowicz, T., Scheithauer, W., Wiltschke, C., & Zielinski, C. C. (2001). Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: Results of a prospective randomised trial. European Journal of Cancer, 37(16), 1994–2002. https://doi.org/10.1016/S0959-8049(01)00132-0

Howard, S. C., McCormick, J., Pui, C., Buddington, R. K., & Harvey, R. D. (2016). Preventing and Managing Toxicities of High‐Dose Methotrexate. The Oncologist, 21(12), 1471–1482. https://doi.org/10.1634/theoncologist.2015-0164

Huang, X., Fang, Q., Rao, T., Zhou, L., Zeng, X., Tan, Z., Chen, L., & Ouyang, D. (2020). Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota. Toxicology and Applied Pharmacology, 391(February), 114900. https://doi.org/10.1016/j.taap.2020.114900

Ibrahim, M. A. A. H., & Elwan, W. M. (2019). Effect of irinotecan on the tongue mucosa of juvenile male albino rat at adulthood. International Journal of Experimental Pathology, 100(4), 244–252. https://doi.org/10.1111/iep.12333

IJpma, I., Renken, R. J., Gietema, J. A., Slart, R. H. J. A., Mensink, M. G. J., Lefrandt, J. D., Ter Horst, G. J., & Reyners, A. K. L. (2016). Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition. Appetite, 105, 392–399. https://doi.org/10.1016/j.appet.2016.06.010

IJpma, I., Timmermans, E. R., Renken, R. J., Ter Horst, G. J., & Reyners, A. K. L. (2017). Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study. Nutrition and Cancer, 69(1), 140–145. https://doi.org/10.1080/01635581.2017.1250922

INCA. (2021). Estatísticas de câncer. https://www.inca.gov.br/numeros-de-cancer

Jensen, S. B., Mouridsen, H. T., Reibel, J., Brünner, N., & Nauntofte, B. (2008). Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncology, 44(2), 162–173. https://doi.org/10.1016/j.oraloncology.2007.01.015

Keefe, D. M. K. (2004). Gastrointestinal mucositis: A new biological model. Supportive Care in Cancer, 12(1), 6–9. https://doi.org/10.1007/s00520-003-0550-9

Kim, M. P., & Gallick, G. E. (2008). Gemcitabine resistance in pancreatic cancer: Picking the key players. Clinical Cancer Research, 14(5), 1284–1285. https://doi.org/10.1158/1078-0432.CCR-07-2247

Kwatra, D., Venugopal, A., Standing, D., Ponnurangam, S., Dhar, A., Mitra, A., & Anant, S. (2013). Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance. Journal of Pharmaceutical Sciences, 102(12), 4444–4454. https://doi.org/10.1002/jps.23753

Lacouture, M., & Sibaud, V. (2018). Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails. American Journal of Clinical Dermatology, 19(s1), 31–39. https://doi.org/10.1007/s40257-018-0384-3

Lee, C. S., Ryan, E. J., & Doherty, G. A. (2014). Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation. World Journal of Gastroenterology, 20(14), 3751–3761. https://doi.org/10.3748/wjg.v20.i14.3751

Mattes, R. D. (2011). Accumulating evidence supports a taste component for free fatty acids in humans. Physiology and Behavior, 104(4), 624–631. https://doi.org/10.1016/j.physbeh.2011.05.002

Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019). Cancer treatment and survivorship statistics, 2019. CA: A Cancer Journal for Clinicians, 69(5), 363–385. https://doi.org/10.3322/caac.21565

Mogi, K., Kamiya, I., Makino, A., Hirao, A., Abe, R., Doi, Y., Shimizu, T., Ando, H., Morito, K., Takayama, K., Ishida, T., & Nagasawa, K. (2021). Liposomalization of Oxaliplatin Exacerbates the Non-Liposomal Formulation-Induced Decrease of Sweet Taste Sensitivity in Rats. Journal of Pharmaceutical Sciences, 000, 1–9. https://doi.org/10.1016/j.xphs.2021.07.004

Mukherjee, N., Pal Choudhuri, S., Delay, R. J., & Delay, E. R. (2017). Cellular mechanisms of cyclophosphamide-induced taste loss in mice. PLoS ONE, 12(9), 1–23. https://doi.org/10.1371/journal.pone.0185473

Neradil, J., Pavlasova, G., & Veselska, R. (2012). New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells. Klinicka Onkologie, 25(SUPPL.2).

Ohishi, A., Nishida, K., Yamanaka, Y., Miyata, A., Ikukawa, A., Yabu, M., Miyamoto, K., Bansho, S., & Nagasawa, K. (2016). Oxaliplatin alters expression of T1R2 receptor and sensitivity to sweet taste in rats. Biological and Pharmaceutical Bulletin, 39(4), 578–586. https://doi.org/10.1248/bpb.b15-00935

Perea-Martinez, I., Nagai, T., & Chaudhari, N. (2013). Functional Cell Types in Taste Buds Have Distinct Longevities. PLoS ONE, 8(1), 1–9. https://doi.org/10.1371/journal.pone.0053399

Pivovarov, K., & Zipursky, J. S. (2019). Low-dose methotrexate toxicity. Cmaj, 191(15), E423. https://doi.org/10.1503/cmaj.181054

Poltronieri, T. S., & Tusset, C. (2016). Impacto do Tratamento do Câncer Sobre o Estado Nutricional de Pacientes oncológicos: Atualização da Literatura. Revista Brasileira de Ciências da Saúde, 20(4), 327–332. https://doi.org/10.4034/rbcs.2016.20.04.10

Postma, E. M., Kok, D. E., de Graaf, C., Kampman, E., & Boesveldt, S. (2020). Chemosensory perception and food preferences in colorectal cancer patients undergoing adjuvant chemotherapy. Clinical Nutrition ESPEN, 40, 242–251. https://doi.org/10.1016/j.clnesp.2020.09.012

Rahnama, M., Madej-Czerwonka, B., Jastrzębska-Jamrogiewicz, I., & Jamrogiewicz, R. (2015). Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa. Wspolczesna Onkologia, 19(1), 77–82. https://doi.org/10.5114/wo.2014.45291

Rivankar, S. (2014). An overview of doxorubicin formulations in cancer therapy. Journal of Cancer Research and Therapeutics, 10(4), 853–858. https://doi.org/10.4103/0973-1482.139267

Rizvi, S. F. A., Tariq, S., & Mehdi, M. (2018). Anthracyclines: Mechanism of action, Classification, Pharmacokinetics and future – a mini review. International Journal of Biotechnology and Bioengineering, 4(4), 81–85.

Sakura, T., Hayakawa, F., Sugiura, I., Murayama, T., Imai, K., Usui, N., Fujisawa, S., Yamauchi, T., Yujiri, T., Kakihana, K., Ito, Y., Kanamori, H., Ueda, Y., Miyata, Y., Kurokawa, M., Asou, N., Ohnishi, K., Ohtake, S., Kobayashi, Y., … Naoe, T. (2018). High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG. Leukemia, 32(3), 626–632. https://doi.org/10.1038/leu.2017.283

Si, M., & Lang, J. (2018). The roles of metallothioneins in carcinogenesis. Journal of Hematology and Oncology, 11(1), 1–20. https://doi.org/10.1186/s13045-018-0645-x

Singh, L., Aldosary, S., Saeedan, A. S., Ansari, M. N., & Kaithwas, G. (2018). Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells. Drug Discovery Today, 23(11), 1873–1882. https://doi.org/10.1016/j.drudis.2018.05.016

Stern, L., Giese, N., Hackert, T., Strobel, O., Schirmacher, P., Felix, K., & Gaida, M. M. (2018). Overcoming chemoresistance in pancreatic cancer cells: Role of the bitter taste receptor T2R10. Journal of Cancer, 9(4), 711–725. https://doi.org/10.7150/jca.21803

Stone, L. M., Tan, S. S., Tam, P. P. L., & Finger, T. E. (2002). Analysis of Cell Lineage Relationships in Taste Buds. Journal of Neuroscience, 22(11), 4522–4529. https://doi.org/10.1523/jneurosci.22-11-04522.2002

Sunariani, J., Rossa, L. M., Yuliati, Y., Diyatri, I., Juliastuti, W. S., & Oki, A. S. (2020). Immunoreactive scoring of metallothionein-3 (MT-3) expression as an indicator of metallic taste rats which are induced by doxorubicin and antioxidant. Malaysian Journal of Medicine and Health Sciences, 16(July), 42–46.

Vasconcelos, N. P. S., Caran, E. M. M., Lee, M. L., Lopes, N. N. F., & Weiler, R. M. E. (2009). Dental maturity assessment in children with acute lymphoblastic leukemia after cancer therapy. Forensic Science International, 184(1–3), 10–14. https://doi.org/10.1016/j.forsciint.2008.11.009

Wennerstrand, P., Mårtensson, L. G., Söderhäll, S., Zimdahl, A., & Appell, M. L. (2013). Methotrexate binds to recombinant thiopurine S-methyltransferase and inhibits enzyme activity after high-dose infusions in childhood leukaemia. European Journal of Clinical Pharmacology, 69(9), 1641–1649. https://doi.org/10.1007/s00228-013-1521-9

Wong, A., Soo, R. A., Yong, W. P., & Innocenti, F. (2009). Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metabolism Reviews, 41(2), 77–88. https://doi.org/10.1080/03602530902741828

Zugazagoitia, J., Guedes, C., Ponce, S., Ferrer, I., Molina-Pinelo, S., & Paz-Ares, L. (2016). Current Challenges in Cancer Treatment. Clinical Therapeutics, 38(7), 1551–1566. https://doi.org/10.1016/j.clinthera.2016.03.026

Downloads

Published

14/11/2021

How to Cite

SILVA, E. H. dos S. .; AGUIAR, Y. L. de .; AMARAL, P. A. S. .; PEREIRA, L. C. . Changes in taste resulting from conventional chemotherapy. Research, Society and Development, [S. l.], v. 10, n. 14, p. e589101422467, 2021. DOI: 10.33448/rsd-v10i14.22467. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/22467. Acesso em: 20 apr. 2024.

Issue

Vol. 10 No. 14

Section

Health Sciences

License

Copyright (c) 2021 Eduardo Henrique dos Santos Silva; Yuri Lopes de Aguiar; Polyana Argolo Souza Amaral; Lara Correia Pereira

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.